- Home
- IMUX vs MPU Comparison
IMUX vs MPU Comparison
Compare IMUX & MPU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMUX
- MPU
- Stock Information
- Founded
- IMUX 2016
- MPU 1989
- Country
- IMUX United States
- MPU Singapore
- Employees
- IMUX N/A
- MPU N/A
- Industry
- IMUX Biotechnology: Pharmaceutical Preparations
- MPU Transportation Services
- Sector
- IMUX Health Care
- MPU Consumer Discretionary
- Exchange
- IMUX Nasdaq
- MPU Nasdaq
- Market Cap
- IMUX 92.2M
- MPU 88.9M
- IPO Year
- IMUX N/A
- MPU 1998
- Fundamental
- Price
- IMUX $0.76
- MPU $0.90
- Analyst Decision
- IMUX Strong Buy
- MPU
- Analyst Count
- IMUX 5
- MPU 0
- Target Price
- IMUX $6.00
- MPU N/A
- AVG Volume (30 Days)
- IMUX 1.3M
- MPU 99.7K
- Earning Date
- IMUX 11-13-2025
- MPU 11-12-2025
- Dividend Yield
- IMUX N/A
- MPU N/A
- EPS Growth
- IMUX N/A
- MPU N/A
- EPS
- IMUX N/A
- MPU N/A
- Revenue
- IMUX N/A
- MPU $35,373,100.00
- Revenue This Year
- IMUX N/A
- MPU N/A
- Revenue Next Year
- IMUX N/A
- MPU N/A
- P/E Ratio
- IMUX N/A
- MPU N/A
- Revenue Growth
- IMUX N/A
- MPU 126.64
- 52 Week Low
- IMUX $0.56
- MPU $0.49
- 52 Week High
- IMUX $1.42
- MPU $4.44
- Technical
- Relative Strength Index (RSI)
- IMUX 47.49
- MPU 31.99
- Support Level
- IMUX $0.67
- MPU $0.96
- Resistance Level
- IMUX $0.79
- MPU $1.03
- Average True Range (ATR)
- IMUX 0.05
- MPU 0.08
- MACD
- IMUX 0.00
- MPU -0.00
- Stochastic Oscillator
- IMUX 64.28
- MPU 0.00
About IMUX Immunic Inc.
Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.
About MPU Mega Matrix Corp.
Mega Matrix Inc is a holding company. It operates through its two subsidiaries Mega Metaverse Corp (Mega) and JetFleet Management Corp (JMC). The Company has two business segments which are comprised of : ETH staking business and The leasing of regional aircraft to foreign and domestic regional airlines. The majority of the company's revenue is earned through Leasing business segment. The company operates in USA and Canada, Asia-Pacific, Europe, Middle East and Africa, and Latin America.